Bristol-Myers Squibb moving 90 manufacturing jobs from New York facility

Bristol-Myers Squibb building
The action reduces the number of employees at the Dewitt plant to 410 from the 503 it employed last year. (Bristol-Myers Squibb)

Bristol-Myers Squibb will move about 90 manufacturing jobs from its DeWitt, New York, facility to plants in Massachusetts and New Jersey.

The changes are part of the company’s restructuring efforts, Pharmafile reported.

Lisa McCormick Lavery, the company’s director of corporate communications, told the publication that the moves are part of a plan to consolidate related positions within the company that includes transferring other positions from company facilities in Connecticut, Indiana and Seattle to the same two sites.

The action reduces the number of employees at the Dewitt plant to 410 from the 503 it employed last year. 

The change is expected to be completed by first-quarter 2019; however, they are not expected to have an effect on manufacturing operations at the DeWitt facility.

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.